STRATEGY for Left Main Coronary Bifurcation Lesion II

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT01798433

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01798433
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01798433. Randomized; no masking; primary purpose treatment. Start 2013-03-18 (actual); primary completion 2018-07-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STRATEGY for Left Main Coronary Bifurcation Lesion II
Acronym
STRATEGY-II
Intervention (Device)
One stent technique alone
Intervention (Device)
One stent technique + Elective FKB
Intervention (Procedure)
Provisional approach
Intervention (Device)
Elective 2-stent
Lead sponsor
Samsung Medical Center (class: other)

Record details

Record id
cardio:ct-nct01798433
Content hash
5ac2643380f483dae72e841313c79d553cf0a423679c03f174eea8c810cea0f5